消化道感染筛查综合诊断套餐
一、套餐名称
中文:(略)
二、特色项目
1.C-(略)呼气试验C-(略)UreaBreathTest
2.幽门螺杆菌培养及药敏试验HelicobacterpyloriCultureandAntimicrobialSusceptibilityTest
3.肠道菌群微生态检测GutMicrobiomeEcologicalAnalysis
4.病原体宏基因测序(mNGS)MetagenomicNext-GenerationSequencing(mNGS)forPathogenDetection
三、套餐临床价值
本套餐通过无创与精准检测技术相结合,全面评估消化道感染性病因:
Thiscomprehensivepanelcombinesnon-invasiveandprecisetechnologiestothoroughlyevaluateinfectiousetiologiesofthedigestivetract:
·C-(略)呼气试验:(略)
C-(略)UreaBreathTest–Painlessandnon-invasive,itprovidesrapiddetectionofactiveH.pyloriinfection,servingasthepreferredtoolforassessingrisksofgastriculcersandchronicgastritis.
·幽门螺杆菌培养及药敏试验:(略)
H.pyloriCultureandSusceptibilityTesting–Identifiesantibioticresistanceprofilesoftheisolatedstrain,enablingtailorederadicationtherapyandreducingfailureratesassociatedwithempiricaltreatment.
·肠道菌群微生态检测:(略)
GutMicrobiomeEcologicalAnalysis–Assessesthebalancebetweenbeneficialandpathogenicgutflora,evaluatesmucosalbarrierfunctionandinflammatorymarkers,offeringevidenceformicrobiome-targetedinterventionsinconditionslikediarrheaandIBD.
·病原体宏基因测序(mNGS):(略)
MetagenomicNext-GenerationSequencing(mNGS)–Unbiased,one-timedetectionofallbacterial,viral,fungal,andparasiticDNA/RNAinstoolordigestivespecimens.Particularlyvaluableforcomplex,severe,orpolymicrobialinfections,itensurespreciseetiologicalidentification.
综合价值:(略)
OverallClinicalValue:(略)infectionstatus→pathogenidentity→drugselection→microbiomerestoration.Itsignificantlyimprovesdiagnosticyieldandcurerateswhileminimizinginappropriateantibioticuse.
阿尔兹海默症综合辅助诊断套餐
一、套餐名称
中文:(略)
二、特色项目
1.载脂蛋白E(APOE)基因基因多态性检测
ApolipoproteinE(APOE)GenePolymorphismAnalysis
2.血浆β-淀粉样蛋白(Aβ(略)、Aβ(略)、Aβ(略)/Aβ(略))检测
PlasmaAmyloid-β(Aβ(略),Aβ(略),andAβ(略)/Aβ(略)Ratio)Assay
3.血浆磷酸化Tau蛋白(p-Tau(略))检测
PlasmaPhosphorylatedTau(p-Tau(略))Detection
三、套餐临床价值
本套餐从“遗传风险预警→早期病理识别→疾病鉴别”三个维度,为阿尔兹海默症提供系统化的辅助诊断依据:
ThispanelprovidesasystematicauxiliarydiagnosticframeworkforAlzheimer‘sdiseaseacrossthreedimensions:geneticriskwarning→earlypathologicalrecognition→diseasedifferentiation:
·遗传风险评估:(略)
GeneticRiskAssessment–APOEgenotypingidentifieslifetimeriskstratificationbeforesymptomonset,helpingtoscreenhigh-riskindividualsandguideregularsurveillanceandlifestyleinterventions.
·早期病理识别:(略)
EarlyPathologicalRecognition–AbnormalplasmaAβ(略)/Aβ(略)ratiocansignalpositivecerebralamyloiddepositionyearsbeforemeasurablecognitivedecline,significantlyadvancingthediagnosticwindow.
·精准鉴别诊断:(略)
PreciseDifferentialDiagnosis–Thecombinationofp-Tau(略)andAβmarkerseffectivelydistinguishesAlzheimer’sdiseasefromothertypesofcognitiveimpairment,includingfrontotemporaldementia,dementiawithLewybodies,andvasculardementia,therebyreducingmisdiagnosis.
综合价值:(略)
Thispanelintegratesthreeblood-basedbiomarkerstocoverthefulldiagnosticcascadeforAlzheimer’sdisease—fromgeneticriskstratificationandearlypathologicaldetectiontodifferentialdiagnosisamongdementias.Itisnon-invasive,repeatable,andsuitableforscreeningasymptomaticindividuals,evaluatingMCIpatients,andguidingclinicaldecisionswithobjective,quantifiableevidence.